No Data
We Think That There Are More Issues For Boji Medical TechnologyLtd (SZSE:300404) Than Just Sluggish Earnings
Broge Pharmaceuticals: 2024 Annual Report
Broge Pharmaceuticals: 2024 Annual Report Summary
Boji Pharmaceuticals: Report for the first quarter of 2025
Boji Medical Technology (300404.SZ): In the first quarter, the net income was 3.9006 million yuan, a year-on-year decrease of 76.38%.
On April 25, Gelonghui reported that Boji Medical Technology (300404.SZ) published its Q1 2025 report, achieving revenue of 0.139 billion yuan, a year-on-year decrease of 17.06%; net income attributable to shareholders of the listed company was 3.9006 million yuan, a year-on-year decrease of 76.38%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 1.6979 million yuan, a year-on-year decrease of 88.28%; basic EPS was 0.0102 yuan.
Boji Medical Technology Co.,Ltd.'s (SZSE:300404) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Market Cool On Boji Medical Technology Co., Ltd.'s (SZSE:300404) Revenues Pushing Shares 25% Lower